Meeder Asset Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-760
| Closed | -$46K | – | 1786 |
|
|
2018
Q4 | $46K | Buy |
760
+643
| +550% | +$38.9K | ﹤0.01% | 833 |
|
|
2018
Q3 | $17K | Buy |
117
+96
| +457% | +$13.9K | ﹤0.01% | 1063 |
|
|
2018
Q2 | $2.61K | Buy |
21
+8
| +62% | +$994 | ﹤0.01% | 1383 |
|
|
2018
Q1 | $1K | Sell |
13
-111
| -90% | -$8.54K | ﹤0.01% | 1459 |
|
|
2017
Q4 | $7K | Sell |
124
-8
| -6% | -$452 | ﹤0.01% | 1225 |
|
|
2017
Q3 | $6K | Buy |
132
+5
| +4% | +$227 | ﹤0.01% | 1210 |
|
|
2017
Q2 | $5K | Buy |
127
+56
| +79% | +$2.21K | ﹤0.01% | 1192 |
|
|
2017
Q1 | $4K | Sell |
71
-447
| -86% | -$25.2K | ﹤0.01% | 1166 |
|
|
2016
Q4 | $20K | Buy |
518
+386
| +292% | +$14.9K | ﹤0.01% | 653 |
|
|
2016
Q3 | $5K | Buy |
+132
| New | +$5K | ﹤0.01% | 720 |
|